Multiparameter magnetic resonance imaging in the diagnosis of prostate cancer

Сергеевич, Коробкин Артем; Шария, М. А.; Восканян, Г. А.; Vinarov, A Z

doi:10.17650/2070-9781-2015-1-53-61

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Использование дополнительных биомаркеров, таких как индекс здоровья предстательной железы (PHI) и тест на 4 калликреина (4K), снижает количество ненужных биопсий на 15-64 %, при этом возникает риск пропуска до 13,5 % случаев клинически значимых форм РПЖ [25,26]. [34,35]. Так, согласно клиническим рекомендациям Европейской ассоциации урологов (European Association of Urology, EAU) выполнение мпМРТ необходимо перед биопсией предстательной железы [8].…”

Section: модификации простатического специфического антигенаunclassified

The role of targeted biopsy methods in the prostate cancer diagnosis

et al. 2021

View full text Add to dashboard Cite

The current prostate cancer screening program results in unnecessary biopsies in a quarter of patients, overdiagnosis of clinically insignificant prostate cancer (ISUP 1) and overtreatment. Intoducing multiparametric magnetic resonance imaging into routine practice before biopsy allows to decrease the number of biopsies, thereby reducing the burden on clinicians and increasing the likelihood of detecting clinically significant forms of prostate cancer (ISUP >2). The objective of this literature review is to compare targeted biopsy techniques and to determine their current role in the prostate cancer diagnosis.

show abstract

Section: модификации простатического специфического антигенаunclassified

The role of targeted biopsy methods in the prostate cancer diagnosis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Результаты недавних исследований, в том числе российских ученых, показали, что при использовании трансперинеальной биопсии с картированием 5 мм было пропущено только 1 из 64 имеющихся ОНКОУРОЛОГИЯ 3'2020 ТОМ 16 CANCER UROLOGY 3'2020 VOL. 16 поражений, у которых визуализируемый объем поражения по данным мпМРТ был ≥0,5 см 3 [84,[86][87][88].…”

unclassified

High-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. From total to focal ablation

Aboian¹,

Pakus²,

Бадьян³

et al. 2020

Onkourologiâ

View full text Add to dashboard Cite

A review of the literature is devoted to the urgent issue of modern oncourology — the treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Currently, there is a trend in shifting the approach from total to focal ablation in patients with prostate cancer of low risk in order to reduce the profile of complications. The article presents the results of modern research on HIFU in both total and focal ablation. Data on oncological, functional results of treatment are given.

show abstract

Multiparameter magnetic resonance imaging in the diagnosis of prostate cancer

Cited by 2 publications

References 10 publications

The role of targeted biopsy methods in the prostate cancer diagnosis

The role of targeted biopsy methods in the prostate cancer diagnosis

High-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. From total to focal ablation

Contact Info

Product

Resources

About